Dr. Claudio Cobelli Presents on “Diabetes: Models, Signals, and Control”

Claudio Cobelli and Boris Kovatchev

Dr. Claudio Cobelli (left) and Dr. Boris Kovatchev (right)

April 28, 2023 | Claudio Cobelli is an Emeritus Professor of Bioengineering at the University of Padova. From 2000 to 2011 he was Chairman of the Graduate Program in Biomedical Engineering and the Ph.D. Program in Bioengineering at the University of Padova. His research activity is in modeling and technology of diabetes. In 1979, he co-authored the now classic Minimal Model of Glucose Kinetics, which set the stage for decades of modeling, computer simulation, and external automated control of the human metabolic system. His research is supported by NIH and the European Community. He is the author of eight books, holds ten patents, and has published 752 papers in internationally refereed journals. He is the Associate Editor of IEEE Transactions on Biomedical Engineering, the Journal of Diabetes Science & Technology, and on the Editorial Board of Diabetes Technology & Therapeutics. Dr. Cobelli was Chairman (1999-2004) of the Italian Bioengineering Group, Chairman (1990-1993 & 1993-1996) of IFAC TC on Modeling and Control of Biomedical Systems. In 2010, he received the Diabetes Technology Artificial Pancreas Research Award. He is a Fellow of IEEE and BMES.

Claudio presenting

Dr. Claudio Cobelli presenting on his background at the University of Padova.

The Center for Diabetes Technology hosted Dr. Cobelli as a guest lecturer for UVA diabetes researchers, students, faculty, and physicians. He spoke about the history and evolution of diabetes models, simulations, and algorithms. He shared about his collaborative work with the CDT on the in silico diabetes simulator and artificial pancreas algorithm. These collaborative efforts allowed the advancement of the artificial pancreas system for clinical use by more than 400,000 persons around the world. He closed with the direction in which the diabetes technology field is heading and provided some advice to the new generation of researchers. Dr. Cobelli stated “…have imagination… diabetes technology research is high risk, but high reward…”.


By: Madison Maloney (